Search

Author/Creator Hellmann, M.D.

1. 3096 First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses. (September 2015)

Authors:
Gettinger, S.N.; Hellmann, M.D.; Shepherd, F.A.; Antonia, S.J.; Brahmer, J.; Chow, L.Q.; Goldman, J.; Juergens, R.; Borghaei, H.; Ready, N.E.; Gerber, D.E.; Nathan, F.; Shen, Y.; Harbison, C.T.; Rizvi, N.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S632
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 3097 Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC). (September 2015)

Authors:
Hellmann, M.D.; Rizvi, N.; Gettinger, S.N.; Goldman, J.; Chow, L.Q.; Juergens, R.; Borghaei, H.; Brahmer, J.; Shen, Y.; Harbison, C.T.; Nathan, F.; Ready, N.E.; Antonia, S.J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S632
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search